Julie S. Barber-Rotenberg

Author

Also Known As

J.S. Barber-Rotenberg, Julie Barber-Rotenberg, Julie Barber‐Rotenberg, Julie S Barber-Rotenberg, Julie S. Barber, Julie S. Barber-Rotenberg

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

University of Pennsylvania Georgetown University Georgetown University Medical Center Parker Institute for Cancer Immunotherapy The Wistar Institute

About

Julie S. Barber-Rotenberg is an author at University of Pennsylvania specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.1K
2	Cell Biology	3	3	489
3	Immunology	3	3	525
4	Natural Sciences	2	2	66
5	Biomolecular Engineering	1	1	41

Julie S. Barber-Rotenberg

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial Vivek Narayan, Julie S. Barber-Rotenberg, In-Young Jung, Nature Medicine UrologyCancer ImmunosurveillanceGenitourinary CancerMedicineImmunology	2022	455
A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma Hayriye V. Erkizan, Yali Kong, Melinda S. Merchant, Nature Medicine Oncogenic AgentPathologyTumor SuppressorMedicineCell Biology	2009	435
PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in Cancer Vito W. Rebecca, Michael C. Nicastri, Colin Fennelly, Cancer Discovery	2018	235
A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling Roles Vito W. Rebecca, Michael C. Nicastri, Noel P. McLaughlin, Cancer Discovery	2017	195
BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion In-Young Jung, Vivek Narayan, Sierra McDonald, Science Translational Medicine	2022	120
Single Enantiomer of YK-4-279 Demonstrates Specificity in Targeting the Oncogene EWS-FLI1 Julie S. Barber-Rotenberg, Saravana P. Selvanathan, Yali Kong, Oncotarget	2012	96
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies Julie K. Jadlowsky, Elizabeth O. Hexner, Amy Marshall, Nature Medicine Human RetrovirusImmunologyAntiviral ResponseAntiviral TherapyAutoimmunity	2025	54
Pharmacokinetic modeling optimizes inhibition of the ‘undruggable’ EWS-FLI1 transcription factor in Ewing Sarcoma Sung-Hyeok Hong, Sarah. E. Youbi, S. Peter Hong, Oncotarget Molecular BiologyCancer BiologyTumor BiologyTranscriptional RegulationEwing Sarcoma	2013	41
Novel peptide binds EWS-FLI1 and reduces the oncogenic potential in Ewing tumors Hayriye V. Erkizan, Lauren Scher, S. Ellen Gamble, Cell Cycle Ewing TumorOncogenic AgentUnique Ewing SarcomaMedicinePathology	2011	29
Acetylation Increases EWS-FLI1 DNA Binding and Transcriptional Activity Silke Schlottmann, Hayriye V. Erkizan, Julie S. Barber-Rotenberg, Frontiers in Oncology	2012	26

Page 1